Loading viewer...
conference
Format: PDF conference
Marinomed Biotech AG presents its strategic evaluation of the Carragelose portfolio, a premium medical device business operating through B2B white label licensing. The company highlights its strength in IP generation and product development, with Carragelose products sold in over 40 countries and self-sustaining revenue growth. The presentation outlines growth potential through ongoing licensing negotiations and newly developed products.
conference
14 Pages
WPX Energy
Teva Pharmaceutical 2024 J.P. Morgan Healthcare Conference
conferenceconference
18 Pages
Teva Pharmaceutical Industries Ltd.
Ironwood Pharmaceuticals 2019 J.P. Morgan Healthcare Conference
conferenceconference
37 Pages
Ironwood Pharmaceuticals